Novo Nordisk expands diabetes cell therapy partnership with Aspect Biosystems [Yahoo! Finance Canada]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance Canada
Aspect will ?lead development and manufacturing and will commercialize the therapies, while Novo Nordisk will ?retain certain options and rights to expand its role later, the companies said. Under the deal, Aspect has acquired rights to certain Novo Nordisk technologies focused on producing insulin-making "islet" cells from stem cells and ?on engineering cells designed ?to be less likely to be attacked by the immune system. The companies did not disclose financial ?terms. Novo Nordisk will make an additional equity investment in Aspect and provide research funding to advance the therapies. The Danish company will also be eligible ?to receive royalties and milestone payments on future product ?sales from Aspect, the companies said. The two companies have collaborated since 2023 to develop cell-based therapies. The deal includes moving some research, development and manufacturing capabilities and expertise from the United States and Denmark into Aspect's Canada-based platfo
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NYSE:NVO) Valuation Check After Sharp 1 Month Rebound And Mixed Long Term Returns [Yahoo! Finance]Yahoo! Finance
- Airlines have 580 million reasons to like GLP-1 weight-loss drugs, analysis finds [Yahoo! Finance]Yahoo! Finance
- Compounder sues Lilly and Novo for suppressing GLP-1RA competition [Yahoo! Finance]Yahoo! Finance
- Drugmakers hike medicine prices in 2026. How much more will you spend? [USA TODAY]USA TODAY
- How Eli Lilly's leader won Trump's favor [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website